Photoaggravated pigmentary disorders such as melasma are often distressing for patients. Prevention of this type of hyperpigmentation has historically focused on protection from ultraviolet radiation; however, the visible light spectrum also has an important role in inducing skin pigmentation. Immediate pigmentation can be induced with as little as 40 Jcm −2 of visible light in phototypes IV to VI, corresponding to an exposure of approximately 15 minutes to mid-summer sun in Texas. 1 Based on the demonstration that visible light induces oxidative stress, studies have demonstrated a potential role for the use of topical antioxidants to protect against visible light.
1 Although they are now frequently used in commercial sunscreens, data regarding the role of topical antioxidants in vivo for visible light protection is scarce. 2 Our study sought to assess the efficacy of a vitamin E cream to prevent pigmentation induced by visible light on subjects of phototypes IV and V.
Visible light exposure was done at an irradiance of 343 mWcm −2 using the same light source as in prior studies evaluating the effects of visible light on skin. 3 Spectroradiometric measurements (Rapid Precision Testing Laboratories, Cordova, Tennessee) of the light source showed minimal infrared and UV radiation emission; visible light represented 99.3% of the irradiance, with 0.016% for total UV and 0.7% for near-infrared irradiances.
Ten healthy adult subjects with skin phototypes IV and V were recruited for this double-blind intrasubject randomised study. The study was approved by an institutional review board, and written informed consent was obtained from each subject. Webber First Aid Cream (J. L. Freeman SEC, Boucherville, Canada) containing vitamin E 20.0% (w/w) (114.0 mg α-tocopherol equivalents/250 IU per gram) was compared to a bland emollient containing no vitamin E (Eucerin cream; Beiersdorf, Hamburg, Germany). The oxygen radical absorbance capacities (ORACs) of both products were tested prior to use (Brunswick Laboratories, Southborough, Massachusetts).
After confirmation that subjects exhibited pigmentation induced by visible light (see table in the supplemental material available on the CMS website), they were randomised to receive application of vitamin E cream at 2 mg/cm 2 on one side of their back and emollient at 2 mg/cm 2 on the other side. To ensure optimal antioxidant effect, each product was applied 24 hours and 30 minutes prior to exposure of 1-cm 2 skin areas to incremental fluences of visible light (55 Jcm ), the protection factor of antioxidant preparation against visible light, and the safety of the antioxidant preparation.
Most subjects were of phototype IV (63.6%), female (63.6%), with a mean age of 35.5 years, and of non-Hispanic ethnicity (72.7%). Visible light exposure induced a significant increase in pigmentation compared to nonexposed skin at both 549 Jcm −2 (ΔL* = 3.36, P < .005 for vitamin E; ΔL* = 3.73, P < .005 for emollient) and 1098 Jcm −2 (ΔL* = 6.85, P < .005 for vitamin E; ΔL* = 6.23, P < .005 for emollient). There was no difference in mean lowest fluence inducing pigmentation 7 days after visible light exposure for vitamin E (480 Jcm −2 ) and for vehicle (370 Jcm −2 ) (P = .182) (Figure 1 ). There was no difference in pigmentation intensity following visible light exposure (L*component of CIELab) between skin with vitamin E and skin with a bland emollient (P = .778 at 549 Jcm −2 ; P = .585 at 1098 Jcm −2 ). Therefore, no pigmentation protection factor could be calculated for the vitamin E formulation.
Our study confirms findings that visible light can induce pigmentation in subjects with darker phototypes and that this pigmentation persists at least 7 days. The current study showed that a cream containing 20% vitamin E did not prevent pigmentation induced by visible light. Although the oxygen radical absorbance capacity of the vitamin E cream confirmed its effect on oxidative stress in vitro, several factors could influence its properties in vivo: the amount of vitamin E absorbed in the skin, the depth of penetration beyond the stratum corneum, the quantity and number of applications necessary for a biologic effect, and the photostability of the product. 4, 5 As chromophores involved in the induction of pigmentation by visible light are not fully known, it is difficult to know where antioxidants should be located to provide optimal protection. Finally, there could also be other oxygenindependent mechanisms involved in visible light-induced pigmentation. 6 In conclusion, a cream containing 20% vitamin E was not effective at preventing visible light-induced pigmentation. Although frequently used in commercial sunscreens, furthers studies on the true biological effects of topical antioxidants on light-induced hyperpigmentation are needed. 
